Floris Dammeijer

3PUBLICATIONS
40CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Sep 10, 2026
PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity.

|Aug 31, 2026
Neutralizing the IL-12/IL-23 p40 subunit prevents immune checkpoint blockade toxicity without compromising antitumor efficacy.

|Jun 22, 2022
Low-Dose JAK3 Inhibition Improves Antitumor T-Cell Immunity and Immunotherapy Efficacy.

Floris Dammeijer, Mandy van Gulijk, Larissa Klaase

Pageof 1

Frequent Collaborators

3 joint publications

Joachim G J V Aerts

2 joint publications

Menno van Nimwegen

2 joint publications

Ralph Stadhouders

2 joint publications

Maria E Joosse

2 joint publications

Rudi W Hendriks

2 joint publications

Mike Eterman

2 joint publications

Nina Rozendaal

1 joint publications

Kan V Lu

1 joint publications

Larissa Klaase

1 joint publications

Robin Hoogenboom

Frequent Collaborators

3 joint publications

Joachim G J V Aerts

2 joint publications

Menno van Nimwegen

2 joint publications

Ralph Stadhouders

2 joint publications

Maria E Joosse

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us